Baek Inho, Bello Alvin Bacero, Jeon Jieun, Arai Yoshie, Cha Byung-Hyun, Kim Byoung Ju, Lee Soo-Hong
Department of Medical Biotechnology, Dongguk University, Goyang, Gyeonggi, Republic of Korea.
Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea.
J Tissue Eng. 2022 Aug 11;13:20417314221116754. doi: 10.1177/20417314221116754. eCollection 2022 Jan-Dec.
Bone growth occurs in the epiphyseal growth plate (EGP) and epiphyseal growth plate cells (EGPCs) exist in EGP. EGPCs, including skeletal stem cells (SSCs), are cells that induce bone growth and development through endochondral ossification. Recently, the superiority of bone regeneration through endochondral ossification has been reported. Our study compared EGPCs with bone marrow-derived mesenchymal stem cells (BM-MSCs) and suggested the therapeutic potential of new bone regeneration. In this study, we analyzed the characteristics between EGPCs and BM-MSCs based on morphological characteristics and molecular profiles. EGPCs expressed chondrogenic and osteogenic markers higher than BM-MSCs. Additionally, in co-culture with BM-MSCs, EGPCs induced an increase in chondrogenic, osteogenic, and hypertrophic markers of BM-MSCs. Finally, EGPCs induced higher bone regeneration than BM-MSCs in the osteoporosis model. Overall, we suggest the possibility of EGPCs as cell therapy for effective bone regeneration.
骨生长发生在骨骺生长板(EGP)中,而骨骺生长板细胞(EGPCs)存在于EGP中。EGPCs,包括骨骼干细胞(SSCs),是通过软骨内成骨诱导骨生长和发育的细胞。最近,有报道称通过软骨内成骨进行骨再生具有优越性。我们的研究将EGPCs与骨髓来源的间充质干细胞(BM-MSCs)进行了比较,并提出了新骨再生的治疗潜力。在本研究中,我们基于形态学特征和分子谱分析了EGPCs与BM-MSCs之间的特性。EGPCs表达的软骨生成和成骨标志物高于BM-MSCs。此外,在与BM-MSCs共培养时,EGPCs诱导BM-MSCs的软骨生成、成骨和肥大标志物增加。最后,在骨质疏松模型中,EGPCs诱导的骨再生高于BM-MSCs。总体而言,我们认为EGPCs作为有效骨再生的细胞治疗方法具有可能性。